CompletedNot Applicable

Inhaled Furosemide for Transient Tachypnea of Newborn

Lebanon64 participantsStarted 2020-01-02

Plain-language summary

This is a randomized double blind clinical trial in which newborns with suspected Transient tachypnea of the newborn (TTN) will receive either furosemide or normal saline by nebulizer every 6 hours for 24 hours.

Who can participate

Age range1 Day – 1 Day

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Neonates with 34+0-39+0 gestational age * on the first day of life * with the clinical diagnosis of Transient Tachypnoea * need for CPAP \>6 hours to obtain the oxygen saturation \>92% Exclusion Criteria: * Systemic infection * Intubation and mechanical ventilation before Inclusion in the trail * Malformation and any other disease with disturb of respiratory system

What they're measuring

Percentage of patients with respiratory morbidity

Timeframe: 24 hours

Trial details

NCT IDNCT04397991

SponsorMakassed General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-01

View on ClinicalTrials.gov More Respiratory Morbidity trials